Randomised evaluation of a specific training of general practitioners in cardiovascular prevention

Acta Cardiologica

Volumn 60, Issue 2, 2005, Pages 199-205

  De Muylder, Régis ^a   Tonglet, René ^a   Nackers, Fabienne ^a   Boland, Benoit ^a,b,c  

^a School of Public Health   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cardiovascular diseases; General practice; Prevention; Training

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; STATINE DERIVATIVE;

ADULT; ARTICLE; ATTITUDE; AWARENESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FAMILY HISTORY; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MALE; MEDICAL EDUCATION; OUTCOMES RESEARCH; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SUDDEN DEATH; EDUCATION; MULTICENTER STUDY; STATISTICAL MODEL;

CARDIOVASCULAR DISEASES; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; HUMANS; LOGISTIC MODELS; PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT;

EID: 19144365785     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.2.2005032     Document Type: Article

References (23)

1. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231-48.
2. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokski E, Amouyel Ph, for the WHO MONICA Project. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999; 353: 1547-57.
3. De Backer G, Ambrosioni E, Borch-Jonhsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faegeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio J, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601-10.
4. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-7.
5. De Henauw S, De Bacquer D, de Smet P, Kornitzer M, De Backer G. Trends in coronary heart disease in two Belgian areas: results from the MONICA Ghent-Charleroi study. J Epidemiol Community Health 1999; 53: 89-98.
6. De Muylder R, Lorant V, Paulus D, Nackers F, Jeanjean M, Boland B. Obstacles to cardiovascular prevention in general practice. Acta Cardiol, 2003; 59(2): 119-25.
7. Grover SA, Lowensteyn I, Ersey K, Steinert Y, Joseph L, Abrahamowicz M. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ 1995; 310: 975-8.
8. McManus RJ, Mant J, Meulendijks CFM, Salter A, Pattison HM, Roalfe AK, Hobbs FDR. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: a cross-sectional study. BMJ 2002; 324: 459-64.
9. EUROASPIRE II group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from Euroaspire II. Eur Heart J 2001; 22: 554-72.
10. EUROASPIRE I and II group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995-1001.
11. Haapanen-Niemi N, Vuori I, Pasanen M. Public health burden of coronary heart disease risk factors among middle-aged and elderly men. Prev Med 1999; 28: 343-8.
12. De Muylder R, Goderis G, Paulus D, Degryse J, Jeanjean M, Boland B. Cardiovascular prevention in general practice: development and validation of an algorithm. Acta Cardiol 2004; 58(6): 598-605.
13. Borduas F, Carrier R, Drouin D, Deslauriers D, Tremblay G. An interactive workshop: An effective means of integrating the Canadian Cardiovascular Society clinical practice guidelines on congestive heart failure into Canadian family physicians' practice. Can J Cardiol 1998; 14: 911-6.
14. Machin D, Campbell M, Fayers P, Pinol A. Sample size tables for clinical studies. Oxford; Blackwell Science, 1997.
15. Gifford DR, Holloway RG, Frankel HR, Albright CL, Meyerson R, Griggs RC. Improving adherence to dementia guidelines through education and opinion leaders. A randomised controlled trial. Ann Intern Med 1999; 131: 237-46.
16. Hosmer DW, Lemeshow S. Applied logistic regression. New York; Wiley, 1989.
17. Barclay S, Todd C, Finlay I, Grande G, Wyatt P. Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs. Fam Pract 2002; 19: 105-11.
18. Grol R. Beliefs and evidence in changing clinical practice. BMJ 1997; 315: 418-21.
19. van der Weijden T, Grol R, Schouten BJ, Knottnerus A. Barriers to working according to cholesterol guidelines: a randomized controlled trial on implementation of national guidelines in 20 general practices. Eur J Public Health 1998; 8: 113-8.
20. Rosenberg W, Donald A. Evidence-based medicine: an approach to clinical problem solving. BMJ 1995; 310: 1122-6.
21. McAlister FA, Graham I, Karr GW, Laupacis A. Evidence-based medicine and the practicing clinician. J Gen Intern Med 1999; 14: 236-42.
22. Malterud K. The art and science of clinical knowledge: evidence beyond measures and numbers. Lancet 2001; 358: 397-400.
23. Gerstein HC, Reddy SS, Dawson KG, Yale JF, Shannon S, Norman G. A controlled evaluation of a national continuing medical education programme designed to improve family physicians' implementation of diabetes-specific clinical practice guidelines. Diabet Med 1999; 16: 964-9.